Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
Más filtros

Bases de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Nature ; 621(7979): 568-576, 2023 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-37704722

RESUMEN

Growth faltering in children (low length for age or low weight for length) during the first 1,000 days of life (from conception to 2 years of age) influences short-term and long-term health and survival1,2. Interventions such as nutritional supplementation during pregnancy and the postnatal period could help prevent growth faltering, but programmatic action has been insufficient to eliminate the high burden of stunting and wasting in low- and middle-income countries. Identification of age windows and population subgroups on which to focus will benefit future preventive efforts. Here we use a population intervention effects analysis of 33 longitudinal cohorts (83,671 children, 662,763 measurements) and 30 separate exposures to show that improving maternal anthropometry and child condition at birth accounted for population increases in length-for-age z-scores of up to 0.40 and weight-for-length z-scores of up to 0.15 by 24 months of age. Boys had consistently higher risk of all forms of growth faltering than girls. Early postnatal growth faltering predisposed children to subsequent and persistent growth faltering. Children with multiple growth deficits exhibited higher mortality rates from birth to 2 years of age than children without growth deficits (hazard ratios 1.9 to 8.7). The importance of prenatal causes and severe consequences for children who experienced early growth faltering support a focus on pre-conception and pregnancy as a key opportunity for new preventive interventions.


Asunto(s)
Caquexia , Países en Desarrollo , Trastornos del Crecimiento , Preescolar , Femenino , Humanos , Lactante , Recién Nacido , Masculino , Embarazo , Caquexia/economía , Caquexia/epidemiología , Caquexia/etiología , Caquexia/prevención & control , Estudios de Cohortes , Países en Desarrollo/economía , Países en Desarrollo/estadística & datos numéricos , Suplementos Dietéticos , Trastornos del Crecimiento/epidemiología , Trastornos del Crecimiento/prevención & control , Estudios Longitudinales , Madres , Factores Sexuales , Desnutrición/economía , Desnutrición/epidemiología , Desnutrición/etiología , Desnutrición/prevención & control , Antropometría
2.
Ophthalmic Plast Reconstr Surg ; 29(2): e51-2, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23128530

RESUMEN

A man with rosacea developed bilateral eyelid edema from wearing a continuous positive airway pressure nasal mask daily. The edema was refractory to steroid, diuretics, and lymphatic drainage massage. The effect may be related to cumulative venous congestion and lymphostasis due to the continuous positive airway pressure treatment.


Asunto(s)
Presión de las Vías Aéreas Positiva Contínua/instrumentación , Edema/etiología , Enfermedades de los Párpados/etiología , Dispositivos de Protección Respiratoria/efectos adversos , Anciano , Humanos , Masculino , Enfermedades Orbitales/etiología , Rosácea/complicaciones
3.
Free Radic Biol Med ; 53(5): 1048-60, 2012 Sep 01.
Artículo en Inglés | MEDLINE | ID: mdl-22796328

RESUMEN

Oxidative stress is frequently implicated in the pathology of neurodegenerative disease. The chief source of this stress is mitochondrial respiration, via the passage of reducing equivalents through the respiratory chain resulting in a small but potentially pathological production of superoxide. The superoxide that is produced during normal respiration is primarily detoxified within the mitochondria by superoxide dismutase 2 (Sod2), a key protein for maintaining mitochondrial function. Mitochondria are distributed throughout the soma of neurons, as well as along neuronal processes and at the synaptic terminus. This distribution of potentially independent mitochondria throughout the neuron, at distinct subcellular locations, allows for the possibility of regional subcellular deficits in mitochondrial function. There has been increasing interest in the quantification and characterization of messages and proteins at the synapse, because of its importance in neurodegenerative disease, most notably Alzheimer disease. Here, we report the transcriptomic and proteomic changes that occur in synaptosomes from frontal cortices of Sod2 null mice. Constitutively Sod2 null mice were differentially dosed with the synthetic catalytic antioxidant EUK-189, which can extend the life span of these mice, as well as uncovering or preventing neurodegeneration due to endogenous oxidative stress. This approach facilitated insight into the quantification of trafficked messages and proteins to the synaptosome. We used two complementary methods to investigate the nature of the synaptosome under oxidative stress: either whole-genome gene expression microarrays or mass spectrometry-based proteomics using isobaric tagging for relative and absolute quantitation of proteins. We characterized the relative enrichment of gene ontologies at both gene and protein expression levels that occurs from mitochondrial oxidative stress in the synaptosome, which may lead to new avenues of investigation in understanding the regulation of synaptic function in normal and diseased states. As a result of using these approaches, we report for the first time an activation of the mTOR pathway in synaptosomes isolated from Sod2 null mice, confirmed by an upregulation of the phosphorylation of 4E-BP1.


Asunto(s)
Mitocondrias/metabolismo , Estrés Oxidativo , Proteómica , Sinaptosomas/metabolismo , Proteínas Adaptadoras Transductoras de Señales , Animales , Antioxidantes/farmacología , Proteínas Portadoras/metabolismo , Proteínas de Ciclo Celular , Factores Eucarióticos de Iniciación , Ratones , Ratones Noqueados , Mitocondrias/efectos de los fármacos , Análisis de Secuencia por Matrices de Oligonucleótidos , Compuestos Organometálicos/farmacología , Estrés Oxidativo/efectos de los fármacos , Fosfoproteínas/metabolismo , Fosforilación , ARN Mensajero/efectos de los fármacos , ARN Mensajero/genética , Salicilatos/farmacología , Transducción de Señal , Superóxido Dismutasa/deficiencia , Superóxido Dismutasa/genética , Superóxido Dismutasa/metabolismo , Sinaptosomas/efectos de los fármacos , Serina-Treonina Quinasas TOR/metabolismo
4.
Sci Transl Med ; 4(119): 119ra13, 2012 Feb 01.
Artículo en Inglés | MEDLINE | ID: mdl-22301554

RESUMEN

Massage therapy is commonly used during physical rehabilitation of skeletal muscle to ameliorate pain and promote recovery from injury. Although there is evidence that massage may relieve pain in injured muscle, how massage affects cellular function remains unknown. To assess the effects of massage, we administered either massage therapy or no treatment to separate quadriceps of 11 young male participants after exercise-induced muscle damage. Muscle biopsies were acquired from the quadriceps (vastus lateralis) at baseline, immediately after 10 min of massage treatment, and after a 2.5-hour period of recovery. We found that massage activated the mechanotransduction signaling pathways focal adhesion kinase (FAK) and extracellular signal-regulated kinase 1/2 (ERK1/2), potentiated mitochondrial biogenesis signaling [nuclear peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α)], and mitigated the rise in nuclear factor κB (NFκB) (p65) nuclear accumulation caused by exercise-induced muscle trauma. Moreover, despite having no effect on muscle metabolites (glycogen, lactate), massage attenuated the production of the inflammatory cytokines tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) and reduced heat shock protein 27 (HSP27) phosphorylation, thereby mitigating cellular stress resulting from myofiber injury. In summary, when administered to skeletal muscle that has been acutely damaged through exercise, massage therapy appears to be clinically beneficial by reducing inflammation and promoting mitochondrial biogenesis.


Asunto(s)
Mediadores de Inflamación/metabolismo , Masaje , Mecanotransducción Celular , Mitocondrias Musculares/metabolismo , Contracción Muscular , Enfermedades Musculares/terapia , Esfuerzo Físico , Músculo Cuádriceps/metabolismo , Biopsia , Complejo IV de Transporte de Electrones/metabolismo , Quinasa 1 de Adhesión Focal/metabolismo , Perfilación de la Expresión Génica/métodos , Regulación de la Expresión Génica , Proteínas de Choque Térmico/metabolismo , Humanos , Interleucina-6/metabolismo , Masculino , Mecanotransducción Celular/genética , Mitocondrias Musculares/patología , Proteína Quinasa 1 Activada por Mitógenos/metabolismo , Proteína Quinasa 3 Activada por Mitógenos/metabolismo , Enfermedades Musculares/genética , Enfermedades Musculares/metabolismo , Enfermedades Musculares/patología , Enfermedades Musculares/fisiopatología , NADH Deshidrogenasa/metabolismo , FN-kappa B/metabolismo , Análisis de Secuencia por Matrices de Oligonucleótidos , Ontario , Coactivador 1-alfa del Receptor Activado por Proliferadores de Peroxisomas gamma , Fosforilación , Músculo Cuádriceps/patología , Músculo Cuádriceps/fisiopatología , Reacción en Cadena en Tiempo Real de la Polimerasa , Recuperación de la Función , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Factores de Tiempo , Factores de Transcripción/metabolismo , Factor de Necrosis Tumoral alfa/metabolismo , Adulto Joven
5.
Integr Cancer Ther ; 10(3): 240-59, 2011 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-21964510

RESUMEN

Although localized colon cancer is often successfully treated with surgery, advanced disease requires aggressive systemic therapy that has lower effectiveness. Approximately 30% to 75% of patients with colon cancer use complementary and alternative medicine (CAM), but there is limited formal evidence of survival efficacy. In a consecutive case series with 10-year follow-up of all colon cancer patients (n = 193) presenting at a San Francisco Bay-Area center for Chinese medicine (Pine Street Clinic, San Anselmo, CA), the authors compared survival in patients choosing short-term treatment lasting the duration of chemotherapy/radiotherapy with those continuing long-term. To put these data into the context of treatment responses seen in conventional medical practice, they also compared survival with Pan-Asian medicine + vitamins (PAM+V) with that of concurrent external controls from Kaiser Permanente Northern California and California Cancer Registries. Kaplan-Meier, traditional Cox regression, and more modern methods were used for causal inference-namely, propensity score and marginal structural models (MSMs), which have not been used before in studies of cancer survival and Chinese herbal medicine. PAM+V combined with conventional therapy, compared with conventional therapy alone, reduced the risk of death in stage I by 95%, stage II by 64%, stage III by 29%, and stage IV by 75%. There was no significant difference between short-term and long-term PAM+V. Combining PAM+V with conventional therapy improved survival, compared with conventional therapy alone, suggesting that prospective trials combining PAM+V with conventional therapy are justified.


Asunto(s)
Neoplasias del Colon/terapia , Medicamentos Herbarios Chinos/administración & dosificación , Medicina Tradicional China/métodos , Puntaje de Propensión , Vitaminas/administración & dosificación , Anciano , Estudios de Cohortes , Neoplasias del Colon/tratamiento farmacológico , Terapia Combinada , Dieta , Ejercicio Físico , Femenino , Estudios de Seguimiento , Medicina de Hierbas/métodos , Humanos , Estimación de Kaplan-Meier , Masculino , Persona de Mediana Edad , Estadificación de Neoplasias/métodos , Modelos de Riesgos Proporcionales , Estudios Prospectivos , Ensayos Clínicos Controlados Aleatorios como Asunto
6.
Integr Cancer Ther ; 10(3): 260-79, 2011 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-21824893

RESUMEN

Complementary and alternative medicines are used by up to 48% of lung cancer patients but have seen little formal assessment of survival efficacy. In this 10-year retrospective survival study, the authors investigated Pan-Asian medicine + vitamins (PAM+V) therapy in a consecutive case series of all non-small-cell lung cancer patients (n = 239) presenting at a San Francisco Bay Area Chinese medicine center (Pine Street Clinic). They compared short-term treatment lasting the duration of chemotherapy/radiotherapy with long-term therapy continuing beyond conventional therapy. They also compared PAM+V plus conventional therapy with conventional therapy alone, using concurrent controls from the Kaiser Permanente Northern California and California Cancer Registries. They adjusted for confounding with Kaplan-Meier, Cox regression, and newer methods - propensity score and marginal structural models (MSMs), which when analyzing data from observational studies or clinical practice records can provide results comparable with randomized trials. Long-term use of PAM+V beyond completion of chemotherapy reduced stage IIIB deaths by 83% and stage IV by 72% compared with short-term use only for the duration of chemotherapy. Long-term PAM+V combined with conventional therapy reduced stage IIIA deaths by 46%, stage IIIB by 62%, and stage IV by 69% compared with conventional therapy alone. Survival rates for stage IV patients treated with PAM+V were 82% at 1 year, 68% at 2 years, and 14% at 5 years. PAM+V combined with conventional therapy improved survival in stages IIIA, IIIB, and IV, compared with conventional therapy alone. Prospective trials using PAM+V with conventional therapy for lung cancer patients are justified.


Asunto(s)
Carcinoma de Pulmón de Células no Pequeñas/terapia , Medicamentos Herbarios Chinos/administración & dosificación , Neoplasias Pulmonares/terapia , Medicina Tradicional China/métodos , Puntaje de Propensión , Vitaminas/administración & dosificación , Anciano , Carcinoma de Pulmón de Células no Pequeñas/tratamiento farmacológico , Terapia Combinada/métodos , Femenino , Estudios de Seguimiento , Medicina de Hierbas/métodos , Humanos , Estimación de Kaplan-Meier , Neoplasias Pulmonares/tratamiento farmacológico , Masculino , Persona de Mediana Edad , Estadificación de Neoplasias/métodos , Modelos de Riesgos Proporcionales , Estudios Prospectivos , Ensayos Clínicos Controlados Aleatorios como Asunto , Estudios Retrospectivos
7.
Exp Gerontol ; 46(6): 441-52, 2011 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-21296648

RESUMEN

Medicinal benefits of Allium vegetables, such as garlic, have been noted throughout recorded history, including protection against cancer and cardiovascular disease. We now demonstrate that garlic constituent diallyl trisulfide (DATS) increases longevity of Caenorhabditis elegans by affecting the skn-1 pathway. Treatment of worms with 5-10 µM DATS increased worm mean lifespan even when treatment is started during young adulthood. To explore the mechanisms involved in the DATS-mediated increase in longevity, we treated daf-2, daf-16, and eat-2 mutants and found that DATS increased the lifespan of daf-2 and daf-16 mutants, but not the eat-2 mutants. Microarray experiments demonstrated that a number of genes regulated by oxidative stress and the skn-1 transcription factor were also changed by DATS treatment. Consistently, DATS treatment leads to the induction of the skn-1 target gene gst-4, and this induction was dependent on skn-1. We also found that the effects of DATS on worm lifespan depend on skn-1 activity in both in the intestine and ASI neurons. Together our data suggest that DATS is able to increase worm lifespan by enhancing the function of the pro-longevity transcription factor skn-1.


Asunto(s)
Compuestos Alílicos/farmacología , Proteínas de Caenorhabditis elegans/metabolismo , Caenorhabditis elegans/fisiología , Proteínas de Unión al ADN/metabolismo , Ajo , Longevidad/efectos de los fármacos , Extractos Vegetales/farmacología , Sulfuros/farmacología , Factores de Transcripción/metabolismo , Animales , Proteínas de Caenorhabditis elegans/efectos de los fármacos , Proteínas de Unión al ADN/efectos de los fármacos , Mucosa Intestinal/metabolismo , Longevidad/fisiología , Análisis por Micromatrices , Modelos Animales , Neuronas/metabolismo , Factores de Transcripción/efectos de los fármacos
8.
PLoS One ; 5(5): e10695, 2010 May 18.
Artículo en Inglés | MEDLINE | ID: mdl-20502695

RESUMEN

Unaccustomed eccentric exercise damages skeletal muscle tissue, activating mechanisms of recovery and remodeling that may be influenced by the female sex hormone 17beta-estradiol (E2). Using high density oligonucleotide based microarrays, we screened for differences in mRNA expression caused by E2 and eccentric exercise. After random assignment to 8 days of either placebo (CON) or E2 (EXP), eighteen men performed 150 single-leg eccentric contractions. Muscle biopsies were collected at baseline (BL), following supplementation (PS), +3 hours (3H) and +48 hours (48H) after exercise. Serum E2 concentrations increased significantly with supplementation (P<0.001) but did not affect microarray results. Exercise led to early transcriptional changes in striated muscle activator of Rho signaling (STARS), Rho family GTPase 3 (RND3), mitogen activated protein kinase (MAPK) regulation and the downstream transcription factor FOS. Targeted RT-PCR analysis identified concurrent induction of negative regulators of calcineurin signaling RCAN (P<0.001) and HMOX1 (P = 0.009). Protein contents were elevated for RND3 at 3H (P = 0.02) and FOS at 48H (P<0.05). These findings indicate that early RhoA and NFAT signaling and regulation are altered following exercise for muscle remodeling and repair, but are not affected by E2.


Asunto(s)
Estradiol/sangre , Ejercicio Físico/fisiología , Regulación de la Expresión Génica , Transducción de Señal/genética , Testosterona/sangre , Transcripción Genética , Actinas/metabolismo , Western Blotting , Suplementos Dietéticos , Humanos , Hipertrofia , L-Lactato Deshidrogenasa/sangre , Masculino , Músculos/patología , Factores de Transcripción NFATC/metabolismo , Análisis de Secuencia por Matrices de Oligonucleótidos , Fosforilación , ARN Mensajero/genética , ARN Mensajero/metabolismo , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Adulto Joven , Proteína de Unión al GTP rhoA/metabolismo
9.
Pediatr Res ; 61(2): 209-14, 2007 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-17237724

RESUMEN

This longitudinal, prospective study sought to establish whether pediatric Crohn's disease (CD) and ulcerative colitis (UC) are associated with increased levels of cytogenetic damage and whether folate supplementation in combination with other treatments mitigates cytogenetic damage in children with inflammatory bowel disease (IBD). After a 1-mo treatment and folate supplementation, all clinical tests in CD (n = 24) and UC (n = 17) patients improved. Patients with CD were comparable in the cytogenetic response with controls (n = 28) assessed by micronucleus (MN) assay, but both groups differed from the UC group. While the MN frequency in epithelial cells slightly decreased from first to second observations in CD patients (p = 0.05) and controls (p = 0.11), an increase was observed in UC patients (p = 0.001). Similar changes were observed in blood lymphocytes resulting in significantly higher levels of the MNs and chromosome bridges in UC patients. These preliminary findings of a difference in chromosome damage between pediatric UC patients compared with CD patients and healthy controls warrant confirmation and expansion to determine (1) the role of cytogenetic damage in the pathogenesis of these diseases, (2) relative contribution of treatment and folate supplementation, and (3) potential links to the eventual development of cancer in some patients.


Asunto(s)
Aberraciones Cromosómicas , Colitis Ulcerosa/tratamiento farmacológico , Enfermedad de Crohn/tratamiento farmacológico , Ácido Fólico/uso terapéutico , Niño , Colitis Ulcerosa/diagnóstico , Colitis Ulcerosa/genética , Enfermedad de Crohn/diagnóstico , Enfermedad de Crohn/genética , Células Epiteliales/citología , Células Epiteliales/metabolismo , Humanos , Linfocitos/sangre , Pruebas de Micronúcleos , Estudios Prospectivos
10.
Integr Cancer Ther ; 5(1): 30-9, 2006 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-16484712

RESUMEN

BACKGROUND: Lung and breast cancers are leading causes of cancer death worldwide. Prior exploratory work has shown that patterns of biochemical markers have been found in the exhaled breath of patients with lung and breast cancers that are distinguishable from those of controls. However, chemical analysis of exhaled breath has not shown suitability for individual clinical diagnosis. METHODS: The authors used a food reward-based method of training 5 ordinary household dogs to distinguish, by scent alone, exhaled breath samples of 55 lung and 31 breast cancer patients from those of 83 healthy controls. A correct indication of cancer samples by the dogs was sitting/lying in front of the sample. A correct response to control samples was to ignore the sample. The authors first trained the dogs in a 3-phase sequential process with gradually increasing levels of challenge. Once trained, the dogs' ability to distinguish cancer patients from controls was then tested using breath samples from subjects not previously encountered by the dogs. The researchers blinded both dog handlers and experimental observers to the identity of breath samples. The diagnostic accuracy data reported were obtained solely from the dogs' sniffing, in double-blinded conditions, of these breath samples obtained from subjects not previously encountered by the dogs during the training period. RESULTS: Among lung cancer patients and controls, overall sensitivity of canine scent detection compared to biopsy-confirmed conventional diagnosis was 0.99 (95% confidence interval [CI], 0.99, 1.00) and overall specificity 0.99 (95% CI, 0.96, 1.00). Among breast cancer patients and controls, sensitivity was 0.88 (95% CI, 0.75, 1.00) and specificity 0.98 (95% CI, 0.90, 0.99). Sensitivity and specificity were remarkably similar across all 4 stages of both diseases. CONCLUSION: Training was efficient and cancer identification was accurate; in a matter of weeks, ordinary household dogs with only basic behavioral "puppy training" were trained to accurately distinguish breath samples of lung and breast cancer patients from those of controls. This pilot work using canine scent detection demonstrates the validity of using a biological system to examine exhaled breath in the diagnostic identification of lung and breast cancers. Future work should closely examine the chemistry of exhaled breath to identify which chemical compounds can most accurately identify the presence of cancer.


Asunto(s)
Neoplasias de la Mama/diagnóstico , Pruebas Respiratorias/métodos , Neoplasias Pulmonares/diagnóstico , Animales , Neoplasias de la Mama/patología , Perros , Método Doble Ciego , Humanos , Neoplasias Pulmonares/patología , Estadificación de Neoplasias , Reproducibilidad de los Resultados , Sensibilidad y Especificidad , Umbral Sensorial , Olfato
11.
Free Radic Biol Med ; 39(2): 152-63, 2005 Jul 15.
Artículo en Inglés | MEDLINE | ID: mdl-15964507

RESUMEN

The majority of cellular superoxide is generated in the mitochondria as a by-product of normal oxidative metabolism. In the mitochondria, superoxide is detoxified by manganese superoxide dismutase (SOD2). Mice lacking SOD2 demonstrate a multifaceted neonatal lethal phenotype, including a spongiform encephalopathy that is preventable through antioxidant treatment. The molecular events behind the observed pathology in the cortex of these mice are unknown. We hypothesized that the lack of SOD2 would result in significant changes in cortical gene expression and that therapeutically beneficial antioxidant treatment would normalize the expression of some genes, providing insight into the mechanism by which mitochondrial oxidative stress results in neurodegeneration. We report the identification of gene expression profiles associated with this paradigm, which characterize the degree of response to the pharmacologic intervention. We have identified specific pathways targeted by endogenous oxidative stress, including glutathione metabolism, iron metabolism, and cell-survival pathways centering on the kinase AKT. The normalization of expression of some of these pathways by antioxidant treatment suggests approaches to treating disease in which endogenous oxidative stress plays a role.


Asunto(s)
Estrés Oxidativo , Farmacogenética/métodos , Enfermedades por Prión/genética , Enfermedades por Prión/metabolismo , Animales , Antioxidantes/metabolismo , Western Blotting , Proliferación Celular , Supervivencia Celular , Análisis por Conglomerados , Biología Computacional , ADN Complementario/metabolismo , Depuradores de Radicales Libres , Regulación de la Expresión Génica , Genotipo , Glutamato-Amoníaco Ligasa/metabolismo , Glutatión/metabolismo , Hierro/metabolismo , Ratones , Mitocondrias/metabolismo , Enfermedades Neurodegenerativas/metabolismo , Fenotipo , Especies Reactivas de Oxígeno , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Superóxido Dismutasa/metabolismo
12.
Am J Trop Med Hyg ; 68(2): 133-9, 2003 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-12641400

RESUMEN

Genotyping frequently is used to distinguish recrudescent from new infections in antimalarial drug efficacy trials, but methodology and interpretation of results have not been standardized. We compared the utility of polymorphisms within 3 Plasmodium falciparum genes during a longitudinal trial in Kampala, Uganda. Merozoite surface protein-1 (msp-1) and merozoite surface protein-2 (msp-2) revealed greater diversity than glutamate-rich protein. Genotypes based on msp-1, msp-2, and all 3 genes combined were compared for 394 initial and subsequent isolates. Classification of most episodes as due to recrudescence or reinfection was straightforward. In 24% (msp-1), 16% (msp-2), and 62% (3 genes combined) of samples, subsequent episodes contained identical and new alleles, however. Our analysis suggested that such episodes should be classified as reinfections and not recrudescence. Comparing the 3 studied genes, msp-2 results were most accurate, and analysis of this single gene effectively distinguished recrudescence from reinfection in our study population.


Asunto(s)
Antimaláricos/uso terapéutico , ADN Protozoario/genética , Malaria Falciparum/tratamiento farmacológico , Plasmodium falciparum/genética , Proteínas Protozoarias/genética , Amodiaquina/uso terapéutico , Animales , Antígenos de Protozoos/genética , Artemisininas/uso terapéutico , Artesunato , Preescolar , Combinación de Medicamentos , Resistencia a Medicamentos , Femenino , Genotipo , Humanos , Lactante , Estudios Longitudinales , Malaria Falciparum/epidemiología , Malaria Falciparum/parasitología , Malaria Falciparum/patología , Masculino , Proteína 1 de Superficie de Merozoito/genética , Plasmodium falciparum/aislamiento & purificación , Reacción en Cadena de la Polimerasa , Pirimetamina/uso terapéutico , Recurrencia , Sesquiterpenos/uso terapéutico , Sulfadoxina/uso terapéutico , Insuficiencia del Tratamiento , Uganda/epidemiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA